HopeStage
Back to all studies
CompletedNCT07116694

Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolarity

Medication studyAges 18–75United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 75 years.

Listed locations
Chino and 4 more locationsSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: June 19, 2025
Recruitment status
Completed
Enrollment listed in the registry
33
Sponsor
BioXcel Therapeutics Inc
Sponsor type
Biotech company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 75 Years
Official registry ID
NCT07116694
Official title
Show the full official title

Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Chino · Oceanside · Orange

2 more locations
  • St Louis
  • Las Vegas

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is BioXcel Therapeutics Inc.

Did this study involve medication?

Yes. The study involved medication, including BXCL501 Sublingual Film.

Who was this study for?

Listed age limits: 18 years to 75 years.

Want to explore more studies?

Explore studies